- Latest week
- 10 Jul 2026
- Close
- 1640.000000
- Fair value
- 1684.912293
- Next-week expectancy
- Negative 5.54%
DJNJ3 Chart Pack
Johnson & Johnson
Chart Summary
Over the latest 12 completed weeks ending 2026-07-10, DJNJ3 was broadly unchanged, moving from 1,640.00 to 1,640.00. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Market Dynamics is -0.30 on the latest week. Next-week expectancy is negative at 5.54% based on similar historical setup states.
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 1,640.00
- 12-Week Change
- 0.00%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Negative 5.54%
- Signal Weeks
- 0 of 12
- Vs Trend Line
- Below
- Vs Fair Value
- Below
- Market Dynamics
- -0.30
Weekly Price
Price Action
Smart Money
Market Dynamics
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 1,640.00
- 12-Week Change
- 0.00%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Negative 5.54%
- Signal Weeks
- 0 of 12
- Vs Trend Line
- Below
- Vs Fair Value
- Below
- Market Dynamics
- -0.30
Over the latest 12 completed weeks ending 2026-07-10, DJNJ3 was broadly unchanged, moving from 1,640.00 to 1,640.00. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Market Dynamics is -0.30 on the latest week. Next-week expectancy is negative at 5.54% based on similar historical setup states.
Industry Peers
Argentina equities in Drug Manufacturers - General
| Stock | Exchange | Week | Open | High | Low | Close | Change |
|---|---|---|---|---|---|---|---|
| PFE Pfizer Inc. | BUE | 10 Jul 2026 | 9540.00 | 9670.00 | 9245.00 | 9490.00 | -0.52% |
| JNJ Johnson & Johnson | BUE | 10 Jul 2026 | 27420.00 | 28280.00 | 26620.00 | 26800.00 | -2.26% |
| BMY Bristol-Myers Squibb Company | BUE | 10 Jul 2026 | 31000.00 | 31000.00 | 29800.00 | 30060.00 | -3.03% |
| MRK Merck & Co., Inc. | BUE | 10 Jul 2026 | 39960.00 | 40780.00 | 38520.00 | 38720.00 | -3.10% |
| GSK GSK plc | BUE | 10 Jul 2026 | 21340.00 | 21340.00 | 20560.00 | 20620.00 | -3.37% |
| LLY Eli Lilly and Company | BUE | 10 Jul 2026 | 34740.00 | 35000.00 | 32880.00 | 33240.00 | -4.32% |
| GILD Gilead Sciences, Inc. | BUE | 10 Jul 2026 | 53225.00 | 56700.00 | 50575.00 | 50825.00 | -4.51% |
| AMGN Amgen Inc. | BUE | 10 Jul 2026 | 19910.00 | 19910.00 | 18830.00 | 18880.00 | -5.17% |
| ABBV AbbVie Inc. | BUE | 10 Jul 2026 | 41120.00 | 41120.00 | 38400.00 | 38720.00 | -5.84% |
| BIIB Biogen Inc. | BUE | 10 Jul 2026 | 26200.00 | 26200.00 | 23660.00 | 24000.00 | -8.40% |
| NVS Novartis AG | BUE | 10 Jul 2026 | 67200.00 | 67200.00 | 60075.00 | 60375.00 | -10.16% |
| AZN AstraZeneca PLC | BUE | 10 Jul 2026 | 80000.00 | 80000.00 | 67050.00 | 67325.00 | -15.84% |